|
Video: What is a Stock Split?
|
|
OpGen is a precision medicine company engaged in molecular diagnostics and informatics. Along with its subsidiaries, Curetis GmbH and Ares Genetics GmbH, Co. is developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information about life threatening infections. Co.'s existing product portfolio includes Unyvero, Acuitas Antimicrobial Resistance (AMR) Gene Panel, and the ARES Technology Platform including ARES reference database on antimicrobial resistance, Next Generation Sequencing technology and Artificial Intelligence-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction. According to our OPGN split history records, OPGN has had 4 splits. | |
|
OPGN (OPGN) has 4 splits in our OPGN split history database. The first split for OPGN took place on January 19, 2018. This was a 1 for 25 reverse split, meaning for each 25 shares of OPGN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split. OPGN's second split took place on August 29, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of OPGN owned pre-split, the shareholder now owned 1 share. For example, a 40 share position pre-split, became a 2 share position following the split. OPGN's third split took place on January 05, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of OPGN owned pre-split, the shareholder now owned 1 share. For example, a 2 share position pre-split, became a 0.1 share position following the split. OPGN's 4th split took place on May 20, 2024. This was a 1 for 10 reverse split, meaning for each 10 shares of OPGN owned pre-split, the shareholder now owned 1 share. For example, a 0.1 share position pre-split, became a 0.01 share position following the split.
When a company such as OPGN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the OPGN split history from start to finish, an original position size of 1000 shares would have turned into 0.01 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OPGN shares, starting with a $10,000 purchase of OPGN, presented on a split-history-adjusted basis factoring in the complete OPGN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/07/2015 |
|
End date: |
10/04/2024 |
|
Start price/share: |
$465,000.00 |
|
End price/share: |
$1.97 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-73.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.04 |
|
Years: |
9.42 |
|
|
|
Date |
Ratio |
01/19/2018 | 1 for 25 | 08/29/2019 | 1 for 20 | 01/05/2023 | 1 for 20 | 05/20/2024 | 1 for 10 |
|
|